AKT1 and cholangiocarcinoma: In a mouse model of CCA, administration of IL-33 in combination with ectopic expression of constitutively active AKT (myr-AKT) and Yes-activated protein (YAP) oncogenes induced tumor development in 72% of mice as compared to 20% in the absence of IL-33.